Page last updated: 2024-08-17

carbostyril and Dyskinesia, Drug-Induced

carbostyril has been researched along with Dyskinesia, Drug-Induced in 49 studies

Research

Studies (49)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (8.16)	18.2507
2000's	33 (67.35)	29.6817
2010's	12 (24.49)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Buchanan, RW; Newcomer, JW; Weiden, PJ	1
Brown, R; Geddes, J; Taylor, MJ	1
Chan, HY; Tan, HK; Wu, WY	1
Huh, L; Lee, BJ	1
Abbasian, C; Power, P	1
Caykoylu, A; Deniz, O; Ekinci, O; Kuloglu, M	1
Bernardi, G; Brusa, L; Iani, C; Mercuri, NB; Moschella, V; Orlacchio, A	1
Adan-Manes, J; Garcia-Parajua, P	1
Dziuba, J; Keshavan, M; Lachover, L; Manji, S; Pizzuti, A; Rajarethinam, R	1
Aia, PG; Esper, CD; Factor, SA; Lungu, C; Shih, LC; Tarsy, D	1
Bernardi, S; Edito, F; Meco, G; Purcaro, C; Stirpe, P; Valente, M; Vanacore, N	1
Christodoulou, C; Douzenis, A; Gournellis, R; Lykouras, LP; Rizos, E	1
Costentin, J	1
Shan, JC; Tseng, MC	1
Agüera-Ortiz, L; Hurtado de Mendoza, A; Osorio, RS; Palomo, T; Ramos, I	1
Agarwal, P; Griffith, A; Hall, DA; Seeberger, LC; Segro, V	1
Chen, HK; Shao, CH; Wu, BJ	1
Friedman, JH	1
Danysz, W; Dekundy, A; Gravius, A; Hechenberger, M; Mela, F; Nagel, J; Parsons, CG; Pietraszek, M; Tober, C; van der Elst, M	1
Ikawa, M; Imai, N	1
Coffey, DB; John, N; Potter, PO	1
Campistol, J; Darling, A; Perez-Duenas, B; Poo, P	1
Goodnick, PJ; Jerry, JM	1
Duggal, HS	1
Cheney, EM; DeQuardo, JR; Sajbel, TA	1
Winter, AS; Witschy, JK	1
Baldessarini, RJ; Grant, MJ	1
Bennett, N; Hirsch, J; Kafantaris, V; Saito, E	1
Annable, L; Beauclair, L; Chouinard, G; Kolivakis, TT; Margolese, HC; Miller, R	1
Hatchett, AD; Zacher, JL	1
Raja, M	1
Maytal, G; Ostacher, M; Stern, TA	1
Ali, IM; Morris, HR; Wickremaratchi, M	1
Clarke, K; Davies, CH; Forbes, IT; Gribble, A; Hill, M; Jones, DN; Newson, M; Reavill, C; Rourke, C; Scott, C; Westaway, J; Wood, MD	1
Limosin, F	1
Brahm, NC; Brown, RC; McElwain, DL	1
Allen, MH; Crandall, DT; Currier, GW; Daniel, DG; Manos, G; McQuade, R; Oren, D; Pikalov, AA; Zimbroff, DL	1
Gournellis, R; Lykouras, L; Rizos, E	1
Evcimen, H; Evcimen, YA; Holland, J	1
Kantrowitz, JT; Srihari, VH; Tek, C	1
Rai, A; Spiegel, D; Urbano, M	1
Lee, C; Lee, CU; Lim, HK; Pae, CU	1
Eudicone, JM; Kim, E; Miller, DD; Pikalov, A	1
Faruqui, RA; Zaidi, SH	1
Gonidakis, F; Papadimitriou, G; Ploubidis, D	1
Ishibashi, S; Iwakura, K; Kawaminami, A; Shindo, Y; Sumi, N; Tawaratani, T; Uchimoto, H; Yoshida, M	1
Ide, M; Iwakura, K; Nagatani, M; Oda, S; Shindo, Y; Sumi, N; Tamura, K	1
Bédard, PJ; Britton, DR; Grondin, R; Shiosaki, K	1
Britton, DR; Jackson, M; Jenner, P; Marsden, CD; Pearce, RK; Shiosaki, K	1

Reviews

7 review(s) available for carbostyril and Dyskinesia, Drug-Induced

Article	Year
Switching antipsychotic medications to reduce adverse event burden in schizophrenia: establishing evidence-based practice. The Journal of clinical psychiatry, 2013, Volume: 74, Issue:11 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Weight; Drug Substitution; Dyskinesia, Drug-Induced; Evidence-Based Medicine; Humans; Lipids; Olanzapine; Patient Outcome Assessment; Piperazines; Psychiatric Status Rating Scales; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology	2013
Aripiprazole alone or in combination for acute mania. The Cochrane database of systematic reviews, 2013, Dec-17, Issue:12 Topics: Adolescent; Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Haloperidol; Humans; Lithium Compounds; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Valproic Acid	2013
[A new approach to antischizophrenic therapeutics: D2 dopamine receptor partial agonists]. Annales pharmaceutiques francaises, 2009, Volume: 67, Issue:5 Topics: Antipsychotic Agents; Aripiprazole; Dopamine Agonists; Drug Design; Dyskinesia, Drug-Induced; History, 20th Century; Humans; Piperazines; Quinolones; Receptors, Dopamine D2; Schizophrenia	2009
[Medication-related oculogyric crises: a description of four cases and a review of the literature]. Revista de neurologia, 2013, Feb-01, Volume: 56, Issue:3 Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Child; Child Behavior Disorders; Child, Preschool; Dopamine; Dopamine Antagonists; Down Syndrome; Dyskinesia, Drug-Induced; Dystonic Disorders; Electroencephalography; Epilepsy; Female; Fragile X Syndrome; Humans; Intellectual Disability; Isoxazoles; Male; Methotrimeprazine; Ocular Motility Disorders; Paliperidone Palmitate; Piperazines; Pyrimidines; Quinolones; Risperidone; Substance Withdrawal Syndrome; Translocation, Genetic; Valproic Acid	2013
Aripiprazole: profile on efficacy and safety. Expert opinion on pharmacotherapy, 2002, Volume: 3, Issue:12 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Brain; Cardiovascular System; Clinical Trials as Topic; Digestive System; Dyskinesia, Drug-Induced; Humans; Mental Disorders; Piperazines; Quinolones; Schizophrenia	2002
Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2005, Volume: 50, Issue:11 Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Dyskinesia, Drug-Induced; Humans; Incidence; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles	2005
[The use of atypical antipsychotics in the long-term care of schizophrenia]. L'Encephale, 2006, Volume: 32 Pt 3 Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Cognition Disorders; Drug Tolerance; Dyskinesia, Drug-Induced; Haloperidol; Humans; Olanzapine; Piperazines; Quinolones; Risperidone; Schizophrenia; Sulpiride; Time Factors	2006

Trials

3 trial(s) available for carbostyril and Dyskinesia, Drug-Induced

Article	Year
Treatment of the symptoms of Huntington's disease: preliminary results comparing aripiprazole and tetrabenazine. Movement disorders : official journal of the Movement Disorder Society, 2009, Jan-15, Volume: 24, Issue:1 Topics: Adult; Aged; Aripiprazole; Cross-Over Studies; Dopamine Agents; Dyskinesia, Drug-Induced; Female; Humans; Huntingtin Protein; Huntington Disease; Hyperkinesis; Male; Middle Aged; Nerve Tissue Proteins; Nuclear Proteins; Piperazines; Quinolones; Receptors, Dopamine D2; Tetrabenazine; Trinucleotide Repeats	2009
Aripiprazole in L-dopa-induced dyskinesias: a one-year open-label pilot study. Journal of neural transmission (Vienna, Austria : 1996), 2009, Volume: 116, Issue:7 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Aripiprazole; Basal Ganglia; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Mianserin; Middle Aged; Mirtazapine; Pilot Projects; Piperazines; Quinolones; Receptors, Dopamine D2; Receptors, Serotonin; Treatment Outcome	2009
Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations. Journal of psychiatric practice, 2007, Volume: 13, Issue:3 Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Quinolones; Schizophrenia	2007

Other Studies

39 other study(ies) available for carbostyril and Dyskinesia, Drug-Induced

Article	Year
Suppression of antipsychotic-induced tardive dyskinesia with aripiprazole in an elderly patient with bipolar I disorder. Acta neuropsychiatrica, 2014, Volume: 26, Issue:1 Topics: Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dyskinesia, Drug-Induced; Humans; Male; Piperazines; Quinolones; Treatment Outcome	2014
Efficacy of aripiprazole in antidepressants-induced tardive dystonia and tardive dyskinesia: a case report. Psychiatria Danubina, 2015, Volume: 27, Issue:2 Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Depressive Disorder, Major; Dyskinesia, Drug-Induced; Dystonic Disorders; Female; Humans; Middle Aged; Piperazines; Quinolones; Treatment Outcome	2015
A case of aripiprazole and tardive dyskinesia. Journal of psychopharmacology (Oxford, England), 2009, Volume: 23, Issue:2 Topics: Antipsychotic Agents; Aripiprazole; Dyskinesia, Drug-Induced; Female; Humans; Piperazines; Quinolones; Schizophrenia; Young Adult	2009
Aripiprazole-induced rabbit syndrome: a case report. Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:3 Topics: Antipsychotic Agents; Aripiprazole; Dopamine D2 Receptor Antagonists; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Piperazines; Quinolones; Syndrome	2010
Aripiprazole in combination with other antipsychotic drugs may worsen psychosis. Journal of clinical pharmacy and therapeutics, 2009, Volume: 34, Issue:2 Topics: Amisulpride; Anti-Dyskinesia Agents; Antipsychotic Agents; Aripiprazole; Biperiden; Dopamine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Male; Piperazines; Psychotic Disorders; Quinolones; Schizophrenia, Paranoid; Schizophrenic Psychology; Sulpiride; Young Adult	2009
Use of aripiprazole in tardive dyskinesia: an open label study of six cases. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2009, Volume: 10, Issue:4 Pt 2 Topics: Adult; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Fluphenazine; Follow-Up Studies; Haloperidol; Humans; Male; Middle Aged; Neurologic Examination; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Risperidone; Schizophrenia	2009
Tardive dyskinesia due to aripiprazole: report of 2 cases. Journal of clinical psychopharmacology, 2009, Volume: 29, Issue:2 Topics: Adult; Antipsychotic Agents; Aripiprazole; Dopamine; Dopamine D2 Receptor Antagonists; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Piperazines; Quinolones	2009
Tardive dyskinesia in a patient treated with quetiapine. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2009, Volume: 10, Issue:1 Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Dibenzothiazepines; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Sulpiride; Thiazoles	2009
Improvement in Pisa syndrome and tardive dyskinesia following aripiprazole treatment. The Journal of neuropsychiatry and clinical neurosciences, 2009,Summer, Volume: 21, Issue:3 Topics: Adult; Antipsychotic Agents; Aripiprazole; Dopamine Agents; Dyskinesia, Drug-Induced; Female; Humans; Piperazines; Quinolones; Schizophrenia; Syndrome; Treatment Outcome	2009
Treatment of tardive dyskinesia with aripiprazole. Neurotoxicity research, 2010, Volume: 17, Issue:4 Topics: Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Dyskinesia, Drug-Induced; Female; Humans; Male; Mood Disorders; Piperazines; Quinolones	2010
Movement disorders associated with aripiprazole use: a case series. The International journal of neuroscience, 2009, Volume: 119, Issue:12 Topics: Aged; Antipsychotic Agents; Aripiprazole; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Male; Middle Aged; Piperazines; Quinolones; Retrospective Studies; Treatment Outcome; Young Adult	2009
Drug-induced Pisa syndrome associated with aripiprazole during clozapine treatment. Progress in neuro-psychopharmacology & biological psychiatry, 2010, May-30, Volume: 34, Issue:4 Topics: Adult; Antipsychotic Agents; Aripiprazole; Clozapine; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Piperazines; Quinolones; Schizophrenia	2010
Tardive dystonia due to aripiprazole use in a neuroleptic-naive patient. The Journal of clinical psychiatry, 2010, Volume: 71, Issue:5 Topics: Antipsychotic Agents; Aripiprazole; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Middle Aged; Piperazines; Quinolones	2010
Pharmacological characterization of MRZ-8676, a novel negative allosteric modulator of subtype 5 metabotropic glutamate receptors (mGluR5): focus on L: -DOPA-induced dyskinesia. Journal of neural transmission (Vienna, Austria : 1996), 2011, Volume: 118, Issue:12 Topics: Adrenergic Agents; Allosteric Regulation; Analysis of Variance; Animals; Brain; Calcium; Cognition Disorders; Conditioning, Psychological; Disease Models, Animal; Dopamine Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Fear; In Vitro Techniques; Levodopa; Male; Maze Learning; Microdialysis; Monoamine Oxidase Inhibitors; Motor Activity; Oxidopamine; Pain Measurement; Parkinson Disease, Secondary; Picolinic Acids; Psychomotor Performance; Quinolones; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Rotarod Performance Test; Tandem Mass Spectrometry; Time Factors	2011
Efficacy of aripiprazole in sulpiride-induced tardive oromandibular dystonia. Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:6 Topics: Aged, 80 and over; Aripiprazole; Dyskinesia, Drug-Induced; Female; Humans; Jaw; Movement Disorders; Piperazines; Quinolones; Sulpiride	2011
Onset of abnormal movements and cardiovascular symptoms after acute change in complex polypharmacy in a child with attention-deficit/hyperactivity disorder and mood symptoms. Journal of child and adolescent psychopharmacology, 2012, Volume: 22, Issue:5 Topics: Adrenergic alpha-Agonists; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Asthma; Attention Deficit Disorder with Hyperactivity; Cardiovascular Diseases; Chest Pain; Child; Dyskinesia, Drug-Induced; Family; Female; Guanfacine; Humans; Lithium Chloride; Male; Mood Disorders; Neuropsychological Tests; Obesity; Paroxetine; Piperazines; Polypharmacy; Pregnancy; Prenatal Exposure Delayed Effects; Psychomotor Agitation; Quinolones; Selective Serotonin Reuptake Inhibitors; Smoking; Social Environment	2012
Aripiprazole-induced improvement in tardive dyskinesia. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2003, Volume: 48, Issue:11 Topics: Adult; Antipsychotic Agents; Aripiprazole; Chronic Disease; Dyskinesia, Drug-Induced; Female; Humans; Piperazines; Psychotic Disorders; Quinolones; Severity of Illness Index	2003
Aripiprazole-associated dyskinesia. The Annals of pharmacotherapy, 2005, Volume: 39, Issue:1 Topics: Adult; Antipsychotic Agents; Aripiprazole; Dyskinesia, Drug-Induced; Humans; Male; Piperazines; Psychotic Disorders; Quinolones	2005
Improvement in tardive dyskinesia with aripiprazole use. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2005, Volume: 50, Issue:3 Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Interactions; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Long-Term Care; Middle Aged; Piperazines; Quinolones; Risperidone; Valproic Acid	2005
Possible improvement of neuroleptic-associated tardive dyskinesia during treatment with aripiprazole. The Annals of pharmacotherapy, 2005, Volume: 39, Issue:11 Topics: Antipsychotic Agents; Aripiprazole; Delusions; Depressive Disorder, Major; Dyskinesia, Drug-Induced; Haloperidol; Humans; Middle Aged; Piperazines; Psychotic Disorders; Quinolones; Treatment Outcome	2005
Treatment of withdrawal dyskinesia. Journal of the American Academy of Child and Adolescent Psychiatry, 2005, Volume: 44, Issue:11 Topics: Adolescent; Amino Acids, Branched-Chain; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Male; Neurologic Examination; Piperazines; Quinolones; Substance Withdrawal Syndrome; Treatment Outcome	2005
Aripiprazole-induced movement disorder. The American journal of psychiatry, 2006, Volume: 163, Issue:1 Topics: Adult; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Humans; Piperazines; Quinolones; Syndrome	2006
Improvement or worsening of psychotic symptoms after treatment with low doses of aripiprazole. The international journal of neuropsychopharmacology, 2007, Volume: 10, Issue:1 Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dopamine Agonists; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Piperazines; Psychoses, Substance-Induced; Psychotic Disorders; Quinolones; Schizophrenia; Serotonin Agents; Treatment Outcome	2007
Aripiprazole-related tardive dyskinesia. CNS spectrums, 2006, Volume: 11, Issue:6 Topics: Antipsychotic Agents; Aripiprazole; Depressive Disorder, Major; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Piperazines; Quinolones	2006
Aripiprazole associated with severe exacerbation of Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:9 Topics: Antipsychotic Agents; Aripiprazole; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Neurologic Examination; Parkinson Disease; Parkinsonian Disorders; Piperazines; Psychotic Disorders; Quinolones	2006
Aripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist properties. European journal of pharmacology, 2006, Sep-28, Volume: 546, Issue:1-3 Topics: Amphetamine; Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Binding, Competitive; Biotransformation; Catalepsy; CHO Cells; Cricetinae; Cricetulus; Dopamine D2 Receptor Antagonists; Dyskinesia, Drug-Induced; Guanosine 5'-O-(3-Thiotriphosphate); HeLa Cells; Humans; Male; Motor Activity; Oxidopamine; Piperazines; Quinolones; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Species Specificity; Transfection	2006
Potential aripiprazole-mediated extrapyramidal symptoms in an adult with developmental disabilities. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2007, Apr-15, Volume: 64, Issue:8 Topics: Adult; Algorithms; Antipsychotic Agents; Aripiprazole; Baclofen; Basal Ganglia Diseases; Citalopram; Diphenhydramine; Drug Interactions; Dyskinesia, Drug-Induced; Humans; Hypnotics and Sedatives; Male; Mental Disorders; Oxazepam; Piperazines; Quinolones	2007
Aripiprazole in the treatment of tardive dyskinesia induced by other atypical antipsychotics. Progress in neuro-psychopharmacology & biological psychiatry, 2007, Oct-01, Volume: 31, Issue:7 Topics: Antipsychotic Agents; Aripiprazole; Dibenzothiazepines; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Piperazines; Quetiapine Fumarate; Quinolones	2007
Aripiprazole-induced tardive dyskinesia: the role of tamoxifen. The American journal of psychiatry, 2007, Volume: 164, Issue:9 Topics: Antipsychotic Agents; Aripiprazole; Dopamine Agonists; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Piperazines; Quinolones; Receptors, Dopamine; Tamoxifen	2007
Resolution of tardive dyskinesia after addition of aripiprazole to haloperidol depot. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:5 Topics: Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Haloperidol; Humans; Male; Middle Aged; Piperazines; Quinolones; Remission Induction; Schizophrenia; Substance-Related Disorders	2007
Atypical antipsychotic withdrawal dyskinesia in 4 patients with mood disorders. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:6 Topics: Adult; Antipsychotic Agents; Aripiprazole; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Mood Disorders; Piperazines; Quinolones; Risperidone; Withholding Treatment	2007
Tardive dystonic symptoms associated with aripiprazole treatment. Progress in neuro-psychopharmacology & biological psychiatry, 2008, Feb-15, Volume: 32, Issue:2 Topics: Adult; Antipsychotic Agents; Aripiprazole; Comorbidity; Dyskinesia, Drug-Induced; Dystonia; Humans; Intellectual Disability; Male; Ocular Motility Disorders; Piperazines; Quinolones; Schizophrenia	2008
Comparative assessment of the incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia: a post hoc analysis. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:12 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Incidence; Male; Middle Aged; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Retrospective Studies; Schizophrenia; Severity of Illness Index	2007
Aripiprazole is associated with early onset of Tardive Dyskinesia like presentation in a patient with ABI and psychosis. Brain injury, 2008, Volume: 22, Issue:1 Topics: Adult; Antipsychotic Agents; Aripiprazole; Brain Injuries; Dyskinesia, Drug-Induced; Humans; Male; Piperazines; Psychotic Disorders; Quinolones; Treatment Outcome; Withholding Treatment	2008
Aripiprazole-induced rabbit syndrome in a drug-naive schizophrenic patient. Schizophrenia research, 2008, Volume: 103, Issue:1-3 Topics: Adult; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Humans; Movement Disorders; Piperazines; Quinolones; Schizophrenia	2008
[A 13-week oral toxicity study of prulifloxacin (NM441) in dogs followed by a 5-week recovery test]. The Journal of toxicological sciences, 1996, Volume: 21 Suppl 1 Topics: Administration, Oral; Alanine Transaminase; Animals; Anti-Infective Agents; Aspartate Aminotransferases; Beta-Globulins; Body Weight; Cartilage, Articular; Dioxolanes; Dogs; Dyskinesia, Drug-Induced; Female; Fluoroquinolones; gamma-Globulins; Male; Piperazines; Quinolones	1996
[A 4-week oral toxicity study of prulifloxacin (NM441) in dogs followed by a 4-week recovery test]. The Journal of toxicological sciences, 1996, Volume: 21 Suppl 1 Topics: Administration, Oral; Alanine Transaminase; Alpha-Globulins; Animals; Anti-Infective Agents; Cartilage, Articular; Dioxolanes; Dogs; Dyskinesia, Drug-Induced; Female; Fluoroquinolones; Kidney; Leukocyte Count; Male; Piperazines; Quinolones	1996
Potential therapeutic use of the selective dopamine D1 receptor agonist, A-86929: an acute study in parkinsonian levodopa-primed monkeys. Neurology, 1997, Volume: 49, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; Motor Activity; Parkinson Disease, Secondary; Quinolones; Quinpirole; Receptors, Dopamine D1; Thiophenes	1997
Actions of the D1 agonists A-77636 and A-86929 on locomotion and dyskinesia in MPTP-treated L-dopa-primed common marmosets. Psychopharmacology, 1999, Volume: 142, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adamantane; Animals; Benzopyrans; Callithrix; Disease Models, Animal; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Female; Levodopa; Locomotion; Male; Quinolones; Receptors, Dopamine D1; Thiophenes	1999